These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20109165)

  • 21. Aspiration risk and postoperative radiation for head and neck cancer.
    Nguyen NP; Frank C; Moltz CC; Millar C; Smith HJ; Dutta S; Alfieri A; Lee H; Vos P; Karlsson U; Nguyen LM; Sallah S
    Cancer Invest; 2009 Jan; 27(1):47-51. PubMed ID: 19160104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
    Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.
    van den Broek GB; Balm AJ; van den Brekel MW; Hauptmann M; Schornagel JH; Rasch CR
    Radiother Oncol; 2006 Nov; 81(2):143-50. PubMed ID: 17055096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspiration in chemoradiated patients with head and neck cancer.
    Langerman A; Maccracken E; Kasza K; Haraf DJ; Vokes EE; Stenson KM
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1289-95. PubMed ID: 18086974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
    Xu B; Boero IJ; Hwang L; Le QT; Moiseenko V; Sanghvi PR; Cohen EE; Mell LK; Murphy JD
    Cancer; 2015 Apr; 121(8):1303-11. PubMed ID: 25537836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
    Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
    Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
    Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life.
    García-Peris P; Parón L; Velasco C; de la Cuerda C; Camblor M; Bretón I; Herencia H; Verdaguer J; Navarro C; Clave P
    Clin Nutr; 2007 Dec; 26(6):710-7. PubMed ID: 17954003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
    Watkins JM; Zauls AJ; Wahlquist AH; Shirai K; Garrett-Mayer E; Gillespie MB; Day TA; Sharma AK
    Laryngoscope; 2010 Feb; 120(2):236-42. PubMed ID: 19950378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of aspiration following radiation for non-nasopharyngeal head and neck cancer.
    Nguyen NP; Frank C; Moltz CC; Millar C; Vos P; Smith HJ; Dutta S; Karlsson U; Nguyen PD; Nguyen LM; Lemanski C; Sallah S
    J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):225-9. PubMed ID: 19128617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
    Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
    J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer.
    Goguen LA; Posner MR; Norris CM; Tishler RB; Wirth LJ; Annino DJ; Gagne A; Sullivan CA; Sammartino DE; Haddad RI
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):916-22. PubMed ID: 16730530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Radiother Oncol; 2010 Oct; 97(1):132-5. PubMed ID: 20817288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer.
    Nguyen NP; Moltz CC; Frank C; Vos P; Smith HJ; Nguyen PD; Nguyen LM; Dutta S; Lemanski C; Sallah S
    Oral Oncol; 2007 Apr; 43(4):352-7. PubMed ID: 16931114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer.
    Fortin A; Wang CS; Vigneault E
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):255-60. PubMed ID: 18632214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.